Robert McRae

Title: The Innovative Contributions of Robert McRae

Introduction

Robert McRae is a notable inventor based in Cardiff, California. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work primarily focuses on methods of treating virally associated cancers, showcasing his commitment to advancing medical science.

Latest Patents

Robert McRae holds a patent for "Methods of treating virally associated cancers with histone deacetylase inhibitors." This patent describes certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Additionally, these schedules and dosing regimens may include treatment with an antiviral agent, highlighting the multifaceted approach to cancer therapy.

Career Highlights

Throughout his career, Robert has demonstrated a strong dedication to research and innovation. He is currently associated with Viracta Therapeutics Inc., a company focused on developing novel therapies for cancer treatment. His work has the potential to significantly impact the lives of patients suffering from virally associated cancers.

Collaborations

Robert McRae has collaborated with esteemed colleagues, including Gail L. Brown and Xiaohu Deng. These partnerships reflect his commitment to teamwork and the sharing of knowledge in the pursuit of medical advancements.

Conclusion

In summary, Robert McRae is an influential inventor whose work in cancer treatment is paving the way for new therapeutic options. His innovative approaches and collaborations are essential in the fight against virally associated cancers.